Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LON002 (Artemether) in Advanced Solid Tumours
NCT02263950Phase 2Unknown
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artemether in solid tumor. Status: unknown.
02
Drugs
artemether
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02263950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263950.